IPSC Repository of Pediatric Cardiovascular Disease
1 other identifier
observational
300
1 country
1
Brief Summary
Obtain blood samples for generation and maintenance of induced pluripotent stem cells (iPSCs) and genomic/DNA sequencing for biomedical research that will improve the understanding and treatment of pediatric cardiovascular disease
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 2, 2021
CompletedFirst Submitted
Initial submission to the registry
August 8, 2022
CompletedFirst Posted
Study publicly available on registry
September 22, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2030
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2030
February 25, 2025
February 1, 2024
9.5 years
August 8, 2022
February 22, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
improve the understanding and treatment of pediatric cardiovascular disease
This is a repository of blood samples that will be used into the future for medical research to improve the understanding and treatment of pediatric cardiovascular disease
up to 10 Years
Study Arms (4)
Affected Subjects
The subjects must have the diagnosis of cardiovascular disease
Syndromes associated with Cardiovascular Disease
The subject must have a syndrome associated with cardiovascular disease
Family Members
The subject must be related to an individual in cohort 1 or 2
Controls
The subject is considered a control and does not fall into any of the other cohorts
Interventions
One time intravenous blood draw
Eligibility Criteria
Any individual with or without pediatric cardiovascular disease
You may qualify if:
- The subjects must have the diagnosis of cardiovascular disease
- The subject must have a syndrome associated with cardiovascular disease
- The subject must be related to an individual in cohort 1 or 2
- The subject is considered a control and does not fall into any of the other cohorts
You may not qualify if:
- N/A
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mingtao Zhaolead
Study Sites (1)
Nationwide Children's Hospital
Columbus, Ohio, 43205, United States
Biospecimen
6-12mL blood sample depending on age of patient
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- FAMILY BASED
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Research Principal Investigator
Study Record Dates
First Submitted
August 8, 2022
First Posted
September 22, 2022
Study Start
July 2, 2021
Primary Completion (Estimated)
December 31, 2030
Study Completion (Estimated)
December 31, 2030
Last Updated
February 25, 2025
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share
Protected health information will only be shared if subjects consent to future research section of informed consent form